Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Patient Advocacy
Pharma
Neurocrine's Prader-Willi med tied to possible safety concerns
A year and a half after the approval of Vykat XR, clinicians connected to the Prader-Willi syndrome community are flagging potential safety concerns.
Fraiser Kansteiner
Aug 13, 2026 9:40am
Zevra CEO drafts big ambitions for Miplyffa's US adoption curve
Jun 3, 2026 11:17am
J&J survey underscores the power of patient community in IBD
Nov 7, 2025 5:00pm
CF buyers club aims to grow access to Vertex's Trikafta
Oct 24, 2025 11:17am
Sarepta shares more Elevidys safety data
Aug 18, 2025 11:32am
Astellas re-ups action week to connect patients, advocacy groups
May 30, 2025 9:35am
